The hepatocardnogenkity of acetoxime has been tentatively linked with its metabolic oxidation to the potent genotoxicant and carcinogen propane 2-nitronate (P2-N). In order to test the hypothesis that acetoxime is metabolized to P2-N, the oxime (20 mM) was incubated with liver microsomes from mice, rats and two humans. Ion-pair HPLC analysis of the incubates afforded a peak that co-eluted with P2-N. P2-N exists in tautomeric equilibrium with 2-nitropropane (2-NP). Samples of the microsomal incubates, which had been adjusted to pH 5.5 and kept for 24 h in order to allow maximal tautomeric equilibration of P2-N to 2-NP to occur, were extracted with hexane. GLC analysis of the extracts yielded a peak that co-eluted with 2-NP, and gave a mass spectrum identical to that of authentic 2-NP. The metabolite peak obtained on HPLC was isolated and its hexane extract contained also 2-NP when investigated by GLC. P2-N was found by HPLC in the urine of rats that had received acetoxime (3.36 mmol/kg i.p.). Hexane extracts of urine samples, which had been adjusted to pH 5.5 and left for 24 h, contained 2-NP as demonstrated by GLC analysis. The results are consistent with the suggestion that the toxidty of acetoxime is associated with its biotransformation to P2-N.
Introduction
Oximes, such as acetoxime, 2-pentanone oxime and cyclohexanone oxime, are used in industry as starting materials in organic synthesis and as anti-skinning agents in paints and coatings. Acetoxime (for structure see Figure 1 ) has been found to produce hepatocellular adenomas in male MRC-Wistar rats (1) . It is also a product of the chemical (2) and metabolic (3) reduction of the hepatocarcinogenic (4) solvent and paint constituent 2-nitropropane (2-NP*). 2-NP (5-8) and particularly propane 2-nitronate (P2-N) (9, 10) , the anion of the 2-NP tautomer propane 2-nitronic acid (Figure 1 ), are potently genotoxic and mutagenic. The P2-N molecule is resonance stabilized, and it can be described by several canonical structures, only one of which is shown in Figure 1 . 2-NP is also a powerful hepatocarcinogen (11, 12) . It has been surmised that acetoxime might cause its hepatocarcinogenicity, wholly or partly, via P2-N as metabolic intermediate (1, 13) . In order to substantiate this conjecture we investigated the hypothesis that P2-N is a metabolite of acetoxime.
•Abbreviations: 2-NP, 2-nitropropane; P2-N, propane 2-nitronate; DEX, dexamethasone: CLO, clofibrate: ISF, isosafrole; 3-MC, 3-methylcholanthrene; /3-NF, /3-naphtholflavone; PCN, pregnenolone-16a-carbonitrile: 1NH, isoniazid: PB, phenobarbitone; ETOH, ethanol: AC, acetone.
To that end suitable chromatographic assays were developed, which distinguish between acetoxime, 2-NP and P2-N. These methods were then used to analyse the products of acetoxime metabolism catalysed by rodent and human hepatic microsomes in vitro. Furthermore, the hypothesis was tested that P2-N or 2-NP are metabolites in the urine of rats that have been exposed to acetoxime.
Materials and methods

Chemicals
Acetoxime and n-octylamine were obtained from Aldrich (Gillingham, UK) and 2-NP, dexamethasone (DEX), clofibrate (CLO) and isosafrole (ISF) from Fluka (Buchs, Switzerland). 2-NP was redistilled prior to use. NADPH, NADP, glucose-6-phosphate, glucose-6-phsphate-dehydrogenase, tetrabutylammonium phosphate, 3-methylcholanthrene (3-MC), 0-naphtholflavone G3-NF) and prcgnenolone-16a-carbonitrile (PCN) were purchased from Sigma (Poole, UK), isoniazid (INH) from Macarthys (Romford, UK), phenobarbitone (PB) from BDH (Poole, UK), and ethanol (ETOH), acetone (AC), n-hexane (GLC pesticide analysis grade) and water (HPLC grade) from Fisons (Loughborough, UK). P2-N was prepared from 2-NP as previously described (2) . Strictly speaking the tautomer of 2-NP is not the nitronate P2-N [structure (iii) in Figure 1 ] but its protonated form propane 2-nitronic acid [structure (ii) in Figure 1 ]. For the sake of simplicity P2-N is meant when the 2-NP tautomer is referred to in the following.
Animals and treatments
Male Sprague-Dawley rats (230-260 g) were purchased from Bantin and Kingman (Hull, UK); male BALB/c mice (25-40 g) were bred at Aston University from Bantin and Kingman breeding stock.
Mice were treated with the following inducers of cytochrome P450: 3-MC (25 mg/kg in com oil, once daily for 3 days i.p.) (14) , /3-NF (80 mg/kg in corn oil, once daily for 3 days i.p.) (15) , ISF (150 mg/kg in com oil, once daily for 3 days i.p.) (16) , PB sodium salt (0.1% w/v in drinking water, for 5 days) (17) , ETOH (10% v/v in drinking water for 14 days) (18) , AC (1% v/v in drinking water for 14 days) (18) , INH (0.1% w/v in drinking water for 10 days) (19) , DEX (300 mg/kg in com oil, once daily for 3 days by gavage) (17) , PCN (50 mg/kg in 0.5% Twcen 80, once daily for 3 days by gavage) (14) and CLO (250 mg/kg in com oil, once daily for 3 days by gavage) (17) . Control animals received the respective vehicles. In the in vivo metabolism study rats received either saline (control animals) or acetoxime (3.36 mmol/kg) (13) dissolved in saline, via the i.p. route. The animals were placed in metabolism cages which allowed separation of unne and faeces. Urine was collected for 76 h. To minimize potential loss of metabolite, urine was kept at <5°C during sampling. All animals had free access to drinking water and Heygate 41B breeding diet.
Preparation of microsomes and microsomal incubations
Animals were killed 24 h after the last dose of inducer. Livers were excised and homogenized in Tris (50 mM)-KCI (0.154 M) buffer (pH 7.4). Excess samples of healthy human liver tissue were obtained from the Liver Transplant Unit (Queen Elizabeth Hospital, Birmingham, UK) after graft reduction of donor livers. These samples were prepared with Coroner's consent and according to a procedure agreed by the local ethical committee. Microsomes were obtained in the usual way (20) by differential centrifugation of homogenate first at 9000 g for 20 min, then at 100 000 g for 1 h in a Beckman L8-60M ultracentrifuge. Microsomal pellets were stored at -72°C or under liquid nitrogen until use. They were thawed, vortexed in Tris-KCI buffer, recentrifuged at 100 000 g for I h and suspended in Tris buffer (0.2 M, pH 7.4). In control experiments microsomes were inactivated by immersion in boiling water for 10 min.
The protein content of the microsomal suspension was determined according to Lowry et at. (21) using bovine serum albumin as standard. Total cytochrome P450 content was estimated as described by Omura and Sato (22) . Microsomes contained the following amounts of cytochrome P450 (expressed as nmol/g original liver): the two human samples 1. Incubates contained microsomes equivalent to 0.25 g original liver per ml of incubate, acetoxime (20 mM) and NADPH (3 mM) in Tris buffer (0.2 M. pH 7.4), the final volume was either 1 ml (analysis by HPLQ or 10 ml (analysis by GLC). In some experiments NADPH was replaced by a NADPH generating system (0.75 mM glucose-6-phosphate, 0.75 mM NADP, 7.5 mM MgCl 2 , 12 units/ml glucose-6-phosphate dehydrogenase). Mixtures were incubated in a shaking waterbath for 30 min at 37 °C. In some experiments incubations were performed in flasks connected to a sealed apparatus, which allowed evacuation of air and introduction of gases, thus providing a defined atmosphere of nitrogen or carbon monoxide/air (50:50 v/v). In one experiment samples were incubated with 0.1 mM n-octylamine at pH 8.4, conditions under which cytochrome P450 is inhibited, but flavin-containing monooxygenases are optimally active (23) .
Sample preparation
For HPLC analysis incubation samples were centrifuged (10 min) at 11 600 g. Tetrabutyl ammonium phosphate (0.5 ml, 10 mM) and methanol (0.5 ml) were added to the supernatant (1 ml). Samples were vortexed (30 s), recemrifuged (10 min, 5000 g) and kept at -15°C until analysis. Aliquots (0.5 ml) of rat unne were diluted with tetrabutyl ammonium phosphate (1.5 ml, 10 mM) and centrifuged (10 min, 6000 r.p.m.). The supernatant was analysed. In the case of GLC analysis samples of microsomal incubate (10 ml) or urine (20 ml) were adjusted to pH 5.5 and left for 24 h at room temperature, conditions for optimal conversion of P2-N to 2-NP (2, 24) . Samples were extracted with 0.5 ml n-hexane. The extract was stored at 4-8°C until analysis.
Analytical methods
HPLC analysis was performed on a Waters 600E multisolvent delivery system equipped with a Waters 700 satellite WISP, a Shimadzu SPD-6A UV-detector, set at 224 run (0.08 AUFS) and a Waters 745B data module, using a 250 x 4 mm C )8 -column (Lichrospher cartridge, end-capped, 5 /un, 100 A) with a C| g precolumn (4x4 mm). Samples were analysed isocratically at 20°C with 5 mM tetrabutyl ammonium phosphate in 10 mM phosphate buffer (pH 6.9) as eluent system. The injection volume was 10 /d, the flow rate 1.0 ml/min, the run time for a sample was 20 min. The metabolic yield in incubates with microsomes from pretreated mice was estimated semi-quantitatively by determination of the ratio of areas of the P2-N and acetoxime peaks. Estimates of amount of P2-N generated by microsomes or found in urine were obtained by comparison with standard P2-N solutions, but without the use of an internal standard.
GLC analysis was conducted on a Hewlett-Packard HP5890 Series II gas chromatograph equipped with a nitrogen/phosphorus-sensitive detector, a HP3396A integrator, and connected to an OV-351 capillary flexsil column (25 m x 0.32 mm, film thickness 0.4 /im; Phase-Sep, Queensferry, UK). The detector gas flow rates were 3.28 ml/min for hydrogen and 77.9 ml/min for air. Helium was used as carrier gas with a flow rate of 1.44 ml/min. Nitrogen (27.4 ml/min) served as make-up gas. Samples (3 jtl) were injected using split injection (split ratio 1:10). The injector temperature was set at 150°C. The oven temperature was kept at 50°C for 10 min, increased by 30°C/min to 180°C, and left there for 5 min. Overall run time was ~ 20 min.
Electron impact mass spectral analysis after GLC separation was carried out using a VG70-70 mass spectrometer coupled to a Carlo Erba HRGC 5160 Mega gas chromatograph. The GLC column attached to the chromatograph was the one described above. The initial oven temperature was 60°C (6 min), followed by a temperature rise to 150°C (30°C/min). Spectra were scanned at 1 s/decade over the mass range 630-20. The source temperature was 200°C, electron energy 70 eV.
Results
An ion-pair HPLC and a capillary GLC method were developed to separate P2-N and 2-NP from acetoxime. Acetoxime was incubated with liver microsomes from mice, rats or two humans, and samples of the incubates were subjected to HPLC analysis. In the presence of microsomes and preformed NADPH a small but detectable peak was identified, with a retention time of 6.7 min, which co-eluted with P2-N ( Figure 2 ). Replacing NADPH with a NADPH-generating system in the incubation mixture yielded an even smaller metabolite peak. The peak was Metabolism of acetoxime not observed in incubates with heat-inactivated microsomes, in the absence of NADPH, or when nitrogen replaced air in the incubation flask. Furthermore the height of the peak was diminished by >80% with a carbon monoxide/air mixture replacing air as incubation atmosphere, and when n-octylamine (0.1 mM) was added to the mixture. Samples of the microsomal incubate were adjusted to pH 5.5 and kept at room temperature for 24 h, which allows maximal tautomeric transformation of P2-N to 2-NP to occur with minimal chemical decomposition (2, 24) . Hexane extracts of this solution were analysed by capillary GLC. Preliminary control experiments established that the recovery of original P2-N as 2-NP was >80%. The gas chromatogram furnished a small peak with a retention time of 8.1 min, which co-eluted with 2-NP (Figure 3 ). This peak was also observed when the hexane extract of the eluent from the HPLC column at the retention time of P2-N was analysed by GLC (result not shown). Electron impact-mass spectral analysis of the GLC peak confirmed its identity as 2-NP. The fragmentation patterns for the metabolite GLC peak and authentic 2-NP are identical (Table I ) and in accordance with the literature (25) . Semi-quantitative evaluation showed that the amount of P2-N generated in the rodent microsomes within 30 min was -20 nmol/nmol cytochrome P450. Comparable amounts were formed in the two human microsomal preparations.
Microsomes were prepared from mice that had been pretreated with several relatively selective inducers of the cytochrome P450 isozymes CYP1A1/CYP1A2 (3-MC, /3-NF, ISF) (16, 26, 27) , CYP2B1/CYP2B2 (PB) (27) , CYP2E1 (ETOH, AC, INH) (18, 19) , CYP3A1 (DEX, PCN) (14, 17) and CYP4A1 (CLO) (17) (cytochrome P450 nomenclature used according to ref. 28 ). Figure 4 shows that metabolite formation as estimated by HPLC in microsomes from animals that had received 3-MC, /3-NF, ISF, PB, ETOH or AC was increased by between 84 and 155% over uninduced levels.
HPLC analysis of urine samples collected from rats that had received acetoxime for up to 76 h showed prolonged excretion of both acetoxime and P2-N. Both species were found at comparable concentrations (0.1 -0.4 mM) over the whole period of urine collection. The identity of the metabolite in the urine samples as P2-N was confirmed by GLC analysis after conversion of the nitronate to 2-NP and hexane extraction.
Discussion
This report provides for the first time unequivocal evidence for the metabolic transformation of acetoxime to P2-N in hepatic tissue from animals and humans. This evidence is based on the chromatographic characterization of the nitronate and its neutral tautomer 2-NP by HPLC and GLC respectively, and on the unambiguous identification of 2-NP by MS. The dependency of metabolite formation on the presence of NADPH and oxygen and its inhibition by carbon monoxide are clearly consistent with the notion that cytochrome P450 plays a role in the catalysis of this biotransformation step. The inducibility of the metabolic oxidation of acetoxime to P2-N by AC, ETOH, 3-MC, |3-NF, ISF and PB points at CYP2E1 and members of the CYP1A and CYP2B subfamilies as the isozymes that catalyse this reaction.
Almost a decade ago the metabolic A/-oxidation of acetoxime was proposed to mediate, fully or in part, the hepatocarcinogenicity of acetoxime in male MRC-Wistar rats (1). More recently a startling similarity was discovered in the pattern of chemically altered nucleosides detectable by HPLC with electrochemical detection in livers of Sprague-Dawley rats that had received either 2-NP or acetoxime (13) . Administration of either compound furnished increased levels of 8-hydroxyguanine in hepatic DNA and RNA and the appearance of as-yet unidentified modified nucleosides, designated DX1 in DNA and RX1 and RX2 in RNA. The detection of 8-hydroxyguanosine and 8-hydroxy-2'-deoxyguanosine is thought to be the result of an attack on guanine residues by reactive oxygen species such as hydroxyl radical or singlet oxygen (29, 30) , and their formation may represent a promutagenic and procarcinogenic lesion (31) . Administration of 2-NP or acetoxime in female rats resulted in significantly lower levels of modified nucleosides in liver nucleic bases compared to those seen in male animals (32) , and the nucleic base modifications caused by acetoxime were weaker than those induced by 2-NP (13) . The implication of these findings is that acetoxime may mediate its carcinogenicity via the generation of reactive oxygen species, probably by way of P2-N as intermediate. In principle, the results of the analytical work presented above are consistent with the reaction sequence: acetoxime-P2-N-reactive oxygen as a mechanistic explanation for acetoxime-induced hepatocarcinogenicity. Nevertheless the amounts of P2-N or its neutral tautomer 2-NP found as metabolites of acetoxime in vitro or in vivo were small. Therefore it is unclear whether metabolic oxidation could contribute in a major way to the deleterious effects of acetoxime. A further complicating twist to the link between metabolism and biological response of oximes and nitroalkanes is provided by the recent finding that 2-NP can undergo cellular reduction to acetoxime (3). Thus acetoxime can be toxified to P2-N via oxidative metabolism; however, it is also generated as a product of the metabolic detoxification of the nitronate or of 2-NP. The corollary of the intriguing metabolic and tautomeric interplay between these species for the mechanisms involved in their toxicities remains to be unravelled with the help of careful quantitative studies, which will allow the genotoxic response and the formation and degeneration of the different species to be correlated.
